that;s the most logical explanation. They intend to present new data, but had to have an abstract ready for registration. You will notice that AAIC does not allow rehashed data to be presented; only original data.
That abstract is old. Only the poster title so far is new, and it announces dose-dependent cognitive improvement, so this is going to be fun as expected.
The plot thickens. It would be a wild guess as to share price action. After loading my boat last week I sent for another boat. I can only wait to see if my yet lower stinkies get hit. I really do not care if share price is sub 4 or 6. I will load the boat same as I always do adding every week. It is an interesting time but I refuse to over analyse instead I will stick to my guns which is to average in for accumulation over time. In this for a very long time which effectively removes short term market risks. Go Anavex Life Sciences
Market Data 
Markets 
AI
